Scrive review

Scrive has no free plan, so the paid entry point is its paid plans at €21. Before any payment, the trial covers 10 documents in 14-day trial. Scrive is an e-signature product (e signature), so a paid plan is the only way to keep signing after the trial ends.

Only a free trial. Scrive lists no free plan, and the trial runs for 14. Once that window closes, signing continues on a paid plan starting at €21, so anyone expecting a permanent free tier should look elsewhere.

The stated limit is 10 documents in 14-day trial, which covers a short burst of signing rather than a busy month. Paired with the free trial of 14 days, that volume is the whole free allowance Scrive offers, and a team sending more will need a paid plan.

The stated audience is small business and enterprise, which points to an in-house signing workflow rather than a consumer tool. Scrive is an e-signature product (e signature) with a paid-only model, so it fits teams that treat document signing as a recurring admin task.

Support runs on help centre, so self-serve articles are the stated route to answers. No live channel appears in the listed support options, which suits users comfortable reading documentation and less so teams that expect to talk to someone when a signature stalls.

Scrive's paid plans start at €21, while DocuSign's plans start at $11. On listed figures Scrive sits at position 164 of 307 brands ranked on entry price, so a buyer chasing the lowest figure has other options in the same category.

Vchasno does, which makes it the pick for a single signature with no budget. Scrive has no free plan and relies on a free trial of 14 days instead, so it suits teams that will sign again after the trial. Privy.id's plans start at IDR 54,000.